Effect of gastric acid resistant coating of fish oil capsules on intestinal uptake of eicosapentaenoic acid and docosahexaenoic acid

Journal of Functional Foods

Volumn 3, Issue 2, 2011, Pages 129-133

  Schneider, Inga ^a   Schuchardt, Jan Philipp ^a   Meyer, Henrike ^a   Hahn, Andreas ^a  

^a LEIBNIZ UNIVERSITY HANNOVER   (Germany)

Author keywords

Absorption; Bioavailability; DHA; Enteric coating; EPA; Omega 3 fatty acids

Indexed keywords

EID: 79954996251     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2011.03.001     Document Type: Article

References (13)

1. Belluzzi A., Brignola C., Campieri M., Camporesi E.P., Gionchetti P., Rizzello F., et al. Effects of new fish oil derivative on fatty acid phospholipid-membrane pattern in a group of Crohn's disease patients. Digestive Diseases and Science 1994, 39:2589-2594.
2. Belluzzi A., Brignola C., Campieri M., Pera A., Boschi S., Miglioli M. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. New England Journal of Medicine 1996, 334:1557-1560.
3. Bézard J., Blond J.P., Bernard A., Clouet P. The metabolism and availability of essential fatty acids in animal and human tissues. Reproduction, Nutrition, Development 1994, 34:539-568.
4. Fetterman J.W., Zdanowicz M.M. Therapeutic potential of n-3 polyunsaturated fatty acids in disease. American Journal of Health System Pharmacy 2009, 66:1169-1179.
5. Iqbal J., Hussain M.M. Intestinal lipid absorption. American Journal of Physiology: Endocrinology and Metabolism 2009, 296:E1183-E1194.
6. Kaminski W.E., Jendraschak E., Kiefl R., von Schacky C. Dietary omega-3 fatty acids lower levels of platelet-derived growth factor mRNA in human mononuclear cells. Blood 1993, 81:1871-1879.
7. Köhler A., Bittner D., Löw A., von Schacky C. Effects of a convenience drink fortified with n-3 fatty acids on the n-3 index. British Journal of Nutrition 2010, 104:729-736.
8. Koletzko B., Lien E., Agostoni C., Böhles H., Campoy C., Cetin I., et al. The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: Review of current knowledge and consensus recommendations. World Association of Perinatal Medicine Dietary Guidelines Working Group. Journal of Perinatal Medicine 2008, 36:5-14.
9. Kurowska E.M., Dresser G.K., Deutsch L., Vachon D., Khalil W. Bioavailability of omega-3 essential fatty acids from perilla seed oil. Prostaglandins, Leukotrienes and Essential Fatty Acids 2003, 68:207-212.
10. Lavie C.J., Milani R.V., Mehra M.R., Ventura H.O. Omega-3 polyunsaturated fatty acids and cardiovascular diseases. Journal of the American College of Cardiology 2009, 54:585-594.
11. Popovic T., Ranic M., Bulajic P., Milicevic M., Arsic A., Vucic V., et al. Effects of n-3 fatty acids supplementation on plasma phospholipids fatty acid composition in patients with obstructive jaundice - A pilot study. Journal of Clinical Biochemistry and Nutrition 2009, 45:370-375.
12. Ruggiero C., Lattanzio F., Lauretani F., Gasperini B., Andres-Lacueva C., Cherubini A. Omega-3 polyunsaturated fatty acids and immune-mediated diseases: Inflammatory bowel disease and rheumatoid arthritis. Current Pharmaceutical Design 2009, 15:4135-4148.
13. Steinijans V.W., Diletti E. Statistical analysis of bioavailability studies: Parametric and nonparametric confidence intervals. European Journal of Clinical Pharmacology 1983, 24:127-136.